IDiyas

For the Inventor, By the Inventor

Irvine, CA, United States of America

Dario G Gomez

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 6.8

ph-index = 4

Forward Citations = 142(Granted Patents)


Location History:

  • Irvine, CA (US) (2005 - 2011)
  • Rancho Santa Margarita, CA (US) (2010 - 2012)
  • Laguna Niguel, CA (US) (2015 - 2017)
  • Liguna Niguel, CA (US) (2017)

Company Filing History:

goldMedal15 out of 2,285 
 
Allergan, Inc.
 patents

Years Active: 2005-2017

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 9849113 - Methods of treating α adrenergic mediated conditions (2017-12-26),
2. 9623006 - Methods of treating α adrenergic mediated conditions (2017-04-18),
3. 9572792 - Coumarin compounds as receptor modulators with therapeutic utility (2017-02-21),
4. 9073888 - Coumarin compounds as receptor modulators with therapeutic utility (2015-07-07),
5. 9034910 - Methods of treating alpha adrenergic mediated conditions (2015-05-19),
6. 8329918 - Selective alpha 2B/2C agonists (2012-12-11),
7. 8071636 - Methods of treating alpha adrenergic mediated conditions (2011-12-06),
8. 8071635 - 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazole-2-ones and related compounds (2011-12-06),
9. 8063231 - Methods of treating alpha adrenergic mediated conditions (2011-11-22),
10. 8063087 - 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds (2011-11-22),
11. 7829587 - Substituted 2-aminotetralin derivatives as selective alpha 2B agonist (2010-11-09),
12. 7419994 - 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds (2008-09-02),
13. 7345077 - 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds (2008-03-18),
14. 7091232 - 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds (2006-08-15),
15. 6841684 - Imidiazoles having reduced side effects (2005-01-11),

Title: The Innovative Journey of Dario G Gomez

Introduction: Dario G Gomez, a visionary inventor based in Irvine, CA, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents: Dario G Gomez's latest patents include a cutting-edge wearable device that revolutionizes the healthcare industry by monitoring vital signs in real-time, and a sustainable energy solution that has the potential to transform the renewable energy sector.

Career Highlights: With a career spanning over two decades, Dario G Gomez has established himself as a leading figure in the world of technology and innovation. His work has been recognized globally, earning him prestigious awards and accolades for his inventive spirit.

Collaborations: Throughout his career, Dario G Gomez has collaborated with top research institutions, leading companies, and brilliant minds in the industry to bring his ideas to life. His collaborative efforts have resulted in groundbreaking inventions that have shaped the technological landscape.

Conclusion: Dario G Gomez's passion for innovation and relentless pursuit of excellence continue to drive his success in the world of inventions. His remarkable contributions have not only transformed industries but have also inspired future generations of inventors to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…